Family members and close friends of people with COVID-19 have elevated symptoms of depression and anxiety, a study from Karolinska Institutet published in The Lancet Regional Health – Europe reports.
The success of this project may enable the development of actionable, personalised interventional strategies to slow down ageing and prevent/delay age-predisposed diseases.
The aims of the ALLTogether study are to improve survival and quality of survival for children and young adults with ALL. ALL in young people has excellent outcome with >90% survival in children and about 75% in young adults. However, patients still die of diseases after relapse as a result of under-treatment.
Cancer in children is rare. But cancer remains the disease causing the most deaths in children over the age of 1 year. Most children, who die from cancer, do so because the standard treatment doesn't make their disease disappear (resistant disease) or because the disease returns (relapse of the disease). These children are at a high risk of dying from their cancer and we need to develop new treatments for them.
In a new report, researchers present six recommendations to optimise the use of the concept of ‘Nordic added value’ across Nordic institutions. The recommendations focus on creating greater cohesion, promoting long-term value and strengthening Nordic identity.
